Diamond Blackfan Anemia Treatment: Past, Present, and Future
- 30 April 2011
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 48 (2), 117-123
- https://doi.org/10.1053/j.seminhematol.2011.01.004
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cellsBlood, 2011
- How I treat Diamond-Blackfan anemiaBlood, 2010
- Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell diseaseProceedings of the National Academy of Sciences of the United States of America, 2010
- Ribosomopathies: human disorders of ribosome dysfunctionBlood, 2010
- A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndromeNature Medicine, 2009
- Treacher Collins syndrome: Unmasking the role of Tcof1/treacleThe International Journal of Biochemistry & Cell Biology, 2009
- Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conferenceBritish Journal of Haematology, 2008
- Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 functionNature Medicine, 2008
- Identification of RPS14 as a 5q- syndrome gene by RNA interference screenNature, 2008
- Tcof1 /Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalitiesProceedings of the National Academy of Sciences of the United States of America, 2006